TABLE 3.
Genomic spatial structure alterations in B cells and macrophages during disease or a certain reaction.
| Cell type | Disease or a certain reaction | Genomic spatial structure alterations |
|---|---|---|
| Macrophage | Anti-tuberculosis infection | The super-enhancer immunogenomic GBP interaction is strong, and NF-κB binds to the enhancer and promoter loops of the PD-L1 gene |
| Anti-infection response | IRF1 increases the chromatin accessibility of ISG gene loci in macrophages | |
| Prostate cancer | The development of malignant tumors is associated with the enrichment of YY1 and H3K27ac at the IL-6 gene enhancer site | |
| Systemic Lupus Erythematosus | The occurrence of the disease is related to the binding of IFN-α and TNF, which leads to the opening of tolerant gene loci, resulting in the appearance of tolerant monocytes | |
| B cell | Diffuse large B-cell lymphoma | The inactivation of the PRDM1 sequence at the TAD boundary in B cell chromatin leads to malignant proliferation of B cells |
| Mantle cell lymphoma (MCL) | The chromosomal interactions in the oncogenic region of SOX11 have significantly increased | |
| Chronic lymphocytic leukemia | The 3D interactions and active enhancers in the EBF1 genomic region within B cells are lost in the early stage of the disease |